


With expansion in the generics market and fewer FDA drug approvals, growth in dollar sales for drugs was down in 2007, though the number of prescriptions dispensed increased slightly.

The FDA directs that all SSRIs contain a black box warning. Patients taking these medications may continue therapy, but they should be monitored carefully on a regular basis.

As summer approaches, it is important to be aware of the harm excessive sun exposure can cause. Pharmacists are in a unique position to increase patient awareness of potential risk factors and assist them in the proper selection and application of sunscreen products.
Advertisement
Advertisement
Trending on Pharmacy Times
1
FDA Announces Recall 580,000 Bottles of Prazosin Over Potential Carcinogenic Impurity
2
From Type 1 to Type 2 and Beyond: Navigating the Landscape of Diabetes
3
COVID-19 Reinfection Heightens Risk of Postacute Sequelae of SARS-CoV-2 in Pediatrics
4
Doxecitine–Doxribtimine Becomes First Approved Treatment for Rare Genetic Disorder
5





